About the editors | bone marrow transplantation

EDITORS-IN-CHIEF   MOHAMAD MOHTY, MD, PHD, SORBONNE UNIVERSITY, PARIS, FRANCE Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the

Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty is also head of a translational research team (INSERM) at the Saint-Antoine Research centre in

Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of immunomodulatory agents. He has a

special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty serves as Scientific

Council Chair of the European Society for Blood and Marrow Transplantation (EBMT) and the “Intergroupe Francophone du Myelome” (IFM). BIPIN SAVANI, MD, VANDERBILT UNIVERSITY MEDICAL CENTER,

UNITED STATES OF AMERICA Dr Savani’s area of specialization is in the treatment of hematological malignancies, stem cell transplantation/ cellular therapy, and his primary field of research

is in the long-term follow-up after transplantation/ cellular therapy, including regimen-related toxicity/ supportive care, and outcomes analysis of hematological malignancies, transplant

and cellular therapy recipients. Dr Savani has published over 500 peer-reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological

malignancies, stem cell transplantation and cellular therapy. Dr Savani is currently leader of the Conditioning Regimen Subcommittee of the Acute Leukemia Working Party of the EBMT. He also

serves as Co-Chair Regimen-Related Toxicity and Supportive Care-CIBMTR and medical monitor for Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). Dr Savani is a member of the ASH

Committee on Practice (COP) and a liaison member from the COP to the ASH Task Force on Immunotherapies subcommittee. He has recently edited several special issues for Seminars in Hematology,

Hematology/ Oncology Clinics of North America and edited Wiley books entitled "Blood and Marrow Transplantation Long Term Management: Prevention and Complications" (first ed 2014,

second ed May 2021) and "Clinical guide to transplantation in lymphomas" (first ed 2015). Co-authored handbook on Leukemia (FAST FACTS: Leukemia, first ed 2019). He has served as

a Foundation for the Accreditation of Cellular Therapy (FACT) adults program clinical/ marrow collection facilities and Immune Effector Cell (IEC) inspector role since 2011. EXECUTIVE EDITOR

  Jakob R Passweg, MD, MS, Basel University Hospital, Switzerland BMT AMBASSADORS Jane F Apperley, MBChB, MD, FRCP, FRCPath, FMedSci, Imperial College London, United Kingdom Robert Peter

Gale, MD, PhD, DSc(hc), FACP, FRCP, FRCP(I), FRSM, Imperial College London, United Kingdom Armand Keating, MD, FRCPC, University of Toronto, Canada Alejandro Madrigal, OBE FMedSci, MD, PhD,

FRCP, FRCPath, DSc, HonDSci, UCL Cancer Institute, United Kingdom Yair Reisner, PhD, Weizmann Institute of Science, Israel ASSOCIATE EDITORS Veronika Bachanova, MD, PhD, University of

Minnesota, United States of America Karen Ballen, MD, University of Virginia Cancer Center, United States of America Ali Bazarbachi, MD, PhD, American University of Beirut, Lebanon Didier

Blaise, MD, Aix Marseille University, France Jaap Jan Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, United States of America Ronjon Chakraverty, MBChB, MRCP, FRCPath, PhD,

University of Oxford, United Kingdom Selim Corbacioglu, MD, PhD, University Medical Center of Regensburg, Germany  Peter Dreger, MD, University of Heidelberg, Germany Nada Hamad, BSc, MSc

Forensic (hons), MBBS (hons), FRACP, FRCPA SpeCetClinRes (Onc), FRCP AFRACMA, St Vincents Hospital Sydney, Australia Ernst Holler, MD, PhD, University Hospital Regensburg, Germany  Myriam

Labopin, MD, MS, Sorbonne University, France Per Ljungman, MD, PhD, Karolinska Institutet, Sweden Florent Malard, MD, PhD, Sorbonne University, France Arnon Nagler, MD, MSc, Chaim Sheba

Medical Center, Israel Miguel-Angel Perales, MD, Memorial Sloan Kettering Cancer Center, United States of America Bart Scott, MD, Fred Hutchinson Cancer Center, United States of America

Lynne Strasfeld, MD, Oregon Health and Science University, United States of America SOCIAL MEDIA EDITOR Florent Malard, MD, PhD, Sorbonne University, France Florent Malard is Associate

Professor of Hematology at the Saint-Antoine Hospital and Sorbonne University. He is also a researcher at the Saint-Antoine research Center in Paris and his research focus on

Graft-versus-Host disease, microbiota and immunological complication of allogeneic hematopoietic stem cell transplantation. He is leading the microbiota working group within the Cellular

Therapy and Immunotherapy Working Party of The EBMT. He has published more than 60 papers in peer-reviewed journals.